Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management

Madison Simons; Tiffany H. Taft

doi:10.1111/apt.16345

Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management

Madison Simons^*, Tiffany H. Taft

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1151-1152
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	53
Issue number	10
DOIs	https://doi.org/10.1111/apt.16345
State	Published - May 2021

ASJC Scopus subject areas

Gastroenterology
Pharmacology (medical)
Hepatology

Access to Document

10.1111/apt.16345

Cite this

@article{4a69834db27843d5a2653d408fbe32c8,

title = "Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management",

author = "Madison Simons and Taft, {Tiffany H.}",

year = "2021",

month = may,

doi = "10.1111/apt.16345",

language = "English (US)",

volume = "53",

pages = "1151--1152",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "10",

}

TY - JOUR

T1 - Editorial

T2 - co-morbid gastrointestinal conditions are an important consideration in IBS management

AU - Simons, Madison

AU - Taft, Tiffany H.

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85104587732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85104587732&partnerID=8YFLogxK

U2 - 10.1111/apt.16345

DO - 10.1111/apt.16345

M3 - Editorial

C2 - 33882166

AN - SCOPUS:85104587732

SN - 0269-2813

VL - 53

SP - 1151

EP - 1152

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 10

ER -

Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this